Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
2.
J Hosp Med ; 13(10): 702-705, 2018 10 01.
Article in English | MEDLINE | ID: mdl-29964277

ABSTRACT

Wide variability exists in the clinical workload of pediatric hospitalists without an accepted standard for benchmarking purposes. By using data obtained from interviews of pediatric hospital medicine (PHM) program leaders, we describe the clinical workload of university-based programs and report on the program sustainability perceived by PHM program leaders. The median clinical hours reported for a full-time pediatric hospitalist were 1800 hours per year, with a median of 15 weekends worked per year. Furthermore, program leaders reported an ideal number of clinical hours as 1700 hours per year. Half of the interviewed program leaders perceived their current models as unsustainable. Programs perceived as unsustainable were more likely than those perceived as sustainable to require a higher number of weekends worked per year or to be university employed. Further research should focus on establishing benchmarks for the workloads of pediatric hospitalists and on evaluating factors that can affect sustainability.


Subject(s)
Hospitalists/statistics & numerical data , Hospitals, Pediatric/statistics & numerical data , Workload/statistics & numerical data , Hospital Administration , Hospitals, University , Humans
3.
Pediatrics ; 139(5)2017 May.
Article in English | MEDLINE | ID: mdl-28557739

ABSTRACT

BACKGROUND: Although meningitis is rare in previously healthy term infants, lumbar puncture is often performed to evaluate for source of illness. This study was performed to determine the time to detection for positive cerebrospinal fluid (CSF) cultures and to provide an update on the current epidemiology of bacterial meningitis in term infants. METHODS: This study was a multicenter, retrospective review of positive CSF cultures in infants ≤90 days of age. Specimens were drawn in the emergency department or inpatient setting between January 2000 and December 2013. Cultures were deemed true pathogens or contaminant species based on the attending physician's treatment plan. Cultures from premature infants, an operative source, or those with significant medical history were excluded. RESULTS: A total of 410 positive CSF culture results were included, with 53 (12.9%) true pathogens and 357 (87.1%) contaminant species. The mean ± SD time to detection for true pathogens was 28.6 ± 16.8 hours (95% confidence interval, 24-33.2); for contaminant species, it was 68.1 ± 36.2 hours (95% confidence interval, 64.3-71.9). Forty-three true-positive cases (81.1%) were positive in ≤36 hours. The most common pathogen was group B Streptococcus (51%), followed by Escherichia coli (13%) and Streptococcus pneumoniae (9%). CONCLUSIONS: The majority of pathogenic bacteria in CSF exhibit growth within 36 hours. Most growth from CSF cultures in febrile infants is treated as contamination. The epidemiology of meningitis has remained constant, with group B Streptococcus as the predominant pathogen, despite changes noted in the epidemiology of bacteremia in this population.


Subject(s)
Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/epidemiology , Spinal Puncture , Bacteremia/diagnosis , Bacteremia/epidemiology , Cerebrospinal Fluid/microbiology , Escherichia coli Infections/diagnosis , Humans , Infant , Infant, Newborn , Pneumococcal Infections/diagnosis , Retrospective Studies , Streptococcal Infections/diagnosis , Streptococcus agalactiae/isolation & purification , Time Factors , United States/epidemiology
4.
Hosp Pediatr ; 3(2): 97-102, 2013 Apr.
Article in English | MEDLINE | ID: mdl-24340409

ABSTRACT

OBJECTIVE: To determine the time to detection (TTD) of positive results on blood, urine, and cerebrospinal fluid (CSF) cultures taken during the evaluation for serious bacterial infection (SBI) in otherwise healthy infants aged 0 to 90 days. METHODS: This study was a retrospective chart review of infants aged 0 to 90 days with positive blood, urine, or CSF cultures drawn during evaluation for SBI in the emergency department or inpatient setting. The TTD of positive culture results, reason for testing, and age of the infant were recorded. RESULTS: A total of 283 charts were reviewed related to 307 positive culture results. Of the 101 positive results on blood culture, 38% were true pathogens with a mean TTD of 13.3 hours; 97% were identified in < or = 36 hours. Blood cultures with TTD > or = 36 hours were 7.8 times more likely to be contaminants compared with those with TTD < 36 hours. Of 192 positive results on urine culture, 58% were true pathogens with a mean TTD of 21 hours; 95% were identified in < or = 36 hours. Fifty percent of 14 positive CSF culture results were true pathogens with a mean TTD of 28.9 hours; 86% were identified in < or = 36 hours. When data for infants < or = 28 days of age were analyzed separately, TTD followed the same patterns for positive blood and urine culture results as seen in all infants aged 0 to 90 days. CONCLUSIONS: In certain clinical situations, the inpatient observation period for infants under evaluation for SBI may be decreased to 36 hours.


Subject(s)
Bacterial Infections , Time Factors , Bacterial Infections/blood , Bacterial Infections/cerebrospinal fluid , Bacterial Infections/urine , Colony Count, Microbial/statistics & numerical data , Humans , Infant , Infant, Newborn , Retrospective Studies
5.
J Hosp Med ; 8(9): 479-85, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23955837

ABSTRACT

BACKGROUND: Despite estimates that waste constitutes up to 20% of healthcare expenditures in the United States, overuse of tests and therapies is significantly under-recognized in medicine, particularly in pediatrics. The American Board of Internal Medicine Foundation developed the Choosing Wisely campaign, which challenged medical societies to develop a list of 5 things physicians and patients should question. The Society of Hospital Medicine (SHM) joined this effort in the spring of 2012. This report provides the pediatric work group's results. METHODS: A work group of experienced and geographically dispersed pediatric hospitalists was convened by the Quality and Safety Committee of the SHM. This group developed an initial list of 20 recommendations, which was pared down through a modified Delphi process to the final 5 listed below. RESULTS: The top 5 recommendations proposed for pediatric hospital medicine are: (1) Do not order chest radiographs in children with asthma or bronchiolitis. (2) Do not use systemic corticosteroids in children under 2 years of age with a lower respiratory tract infection. (3) Do not use bronchodilators in children with bronchiolitis. (4) Do not treat gastroesophageal reflux in infants routinely with acid suppression therapy. (5) Do not use continuous pulse oximetry routinely in children with acute respiratory illness unless they are on supplemental oxygen. CONCLUSION: We recommend that pediatric hospitalists use this list to prioritize quality improvement efforts and include issues of waste and overuse in their efforts to improve patient care.


Subject(s)
Choice Behavior , Hospital Medicine/standards , Hospitalists/standards , Hospitals, Pediatric/standards , Practice Guidelines as Topic/standards , Quality of Health Care/standards , Hospital Medicine/methods , Humans , Societies, Medical/standards , United States
6.
J Hosp Med ; 8(1): 25-30, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23047831

ABSTRACT

BACKGROUND: Acute viral bronchiolitis is the most common diagnosis resulting in hospital admission in pediatrics. Utilization of non-evidence-based therapies and testing remains common despite a large volume of evidence to guide quality improvement efforts. OBJECTIVE: Our objective was to reduce utilization of unnecessary therapies in the inpatient care of bronchiolitis across a diverse network of clinical sites. METHODS: We formed a voluntary quality improvement collaborative of pediatric hospitalists for the purpose of benchmarking the use of bronchodilators, steroids, chest radiography, chest physiotherapy, and viral testing in bronchiolitis using hospital administrative data. We shared resources within the network, including protocols, scores, order sets, and key bibliographies, and established group norms for decreasing utilization. RESULTS: Aggregate data on 11,568 hospitalizations for bronchiolitis from 17 centers was analyzed for this report. The network was organized in 2008. By 2010, we saw a 46% reduction in overall volume of bronchodilators used, a 3.4 dose per patient absolute decrease in utilization (95% confidence interval [CI] 1.4-5.8). Overall exposure to any dose of bronchodilator decreased by 12 percentage points as well (95% CI 5%-25%). There was also a statistically significant decline in chest physiotherapy usage, but not for steroids, chest radiography, or viral testing. CONCLUSIONS: Benchmarking within a voluntary pediatric hospitalist collaborative facilitated decreased utilization of bronchodilators and chest physiotherapy in bronchiolitis.


Subject(s)
Benchmarking/statistics & numerical data , Bronchiolitis/drug therapy , Bronchodilator Agents/standards , Evidence-Based Practice/standards , Steroids/standards , Acute Disease , Benchmarking/methods , Benchmarking/standards , Bronchiolitis/diagnostic imaging , Bronchiolitis/economics , Bronchodilator Agents/administration & dosage , Bronchodilator Agents/therapeutic use , Cooperative Behavior , Costs and Cost Analysis , Evidence-Based Practice/statistics & numerical data , Guideline Adherence/statistics & numerical data , Hospitals, Pediatric/standards , Hospitals, Pediatric/statistics & numerical data , Humans , Infant , Interinstitutional Relations , Physical Therapy Modalities/standards , Physical Therapy Modalities/statistics & numerical data , Practice Guidelines as Topic , Quality Improvement/standards , Quality Improvement/statistics & numerical data , Radiography, Thoracic/statistics & numerical data , Steroids/administration & dosage , Steroids/therapeutic use , United States
7.
Int J Pediatr Otorhinolaryngol ; 77(1): 65-8, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23131201

ABSTRACT

OBJECTIVES: To estimate the prevalence of operative ear disease in pediatric patients with tracheostomy tubes, as well as to identify risk factors predictive of operative otologic interventions in this patient cohort. METHODS: We hypothesize that the prevalence of operative middle ear disease in patients with a tracheostomy tube is greater than that of the population at large. To validate our anecdotal observations, we queried the CHCA hospital database (PHIS) regarding the association between tympanostomy tube placements in children with tracheostomies. To further investigate, a retrospective chart review was undertaken at our regional tertiary care children's hospital to determine the frequency at which tympanostomy tubes were placed in children who have a tracheostomy. Risk factors were analyzed, applying independent samples t-tests and Pearson's Chi-square test. Univariate and multivariate logistic regression models were constructed to estimate odds ratios (OR) and 95% confidence intervals (CI) for predictors of operative ear disease. Institutional review board (IRB) approval was obtained. RESULTS: Of a population of 181 patients with tracheostomies, 37 (or 20%, 95% CI 15-26%) have undergone placement of ventilation tubes in the past 3 years. No statistically significant difference was noted with regards to gender or race. The operative group had an average age of 23.0 months at the time of tracheostomy, compared to 52.5 months in the non-operative group (p=0.0022). In addition, home living situation, term birth, and craniofacial abnormalities were more frequently observed in the operative versus the non-operative group. Multivariate logistic regression models revealed the same factors as predictors of operative ear disease. CONCLUSION: The presence of a tracheostomy is associated with an increased risk of requiring ventilation tube placement over the population at large. Risk factors for operative middle ear disease among these children include age at time of the tracheostomy, craniofacial abnormalities, term birth, and home living situation.


Subject(s)
Airway Obstruction/surgery , Middle Ear Ventilation/statistics & numerical data , Otitis Media with Effusion/surgery , Tracheostomy/statistics & numerical data , Age Factors , Airway Obstruction/complications , Airway Obstruction/diagnosis , Analysis of Variance , Chi-Square Distribution , Child, Preschool , Cohort Studies , Databases, Factual , Female , Hospitals, Pediatric , Humans , Infant , Logistic Models , Male , Middle Ear Ventilation/methods , Multivariate Analysis , Otitis Media with Effusion/complications , Prevalence , Prognosis , Retrospective Studies , Risk Assessment , Sex Factors , Tertiary Care Centers , Tracheostomy/methods , United States
8.
J Hosp Med ; 6(5): 256-63, 2011 May.
Article in English | MEDLINE | ID: mdl-21374798

ABSTRACT

OBJECTIVE: To determine the comparative effectiveness of common pleural drainage procedures for treatment of pneumonia complicated by parapneumonic effusion (ie, complicated pneumonia). DESIGN: Multicenter retrospective cohort study. SETTING: Forty children's hospitals contributing data to the Pediatric Health Information System. PARTICIPANTS: Children with complicated pneumonia requiring pleural drainage. MAIN EXPOSURES: Initial drainage procedures were categorized as chest tube without fibrinolysis, chest tube with fibrinolysis, video-assisted thoracoscopic surgery (VATS), and thoracotomy. MAIN OUTCOME MEASURES: Length of stay (LOS), additional drainage procedures, readmission within 14 days of discharge, and hospital costs. RESULTS: Initial procedures among 3500 patients included chest tube without fibrinolysis (n = 1762), chest tube with fibrinolysis (n = 623), VATS (n = 408), and thoracotomy (n = 797). Median age was 4.1 years. Overall, 716 (20.5%) patients received an additional drainage procedure (range, 6.8-44.8% across individual hospitals). The median LOS was 10 days (range, 7-14 days across individual hospitals). The median readmission rate was 3.8% (range, 0.8%-33.3%). In multivariable analysis, differences in LOS by initial procedure type were not significant. Patients undergoing initial chest tube placement with or without fibrinolysis were more likely to require additional drainage procedures. However, initial chest tube without fibrinolysis was the least costly strategy. CONCLUSION: There is variability in the treatment and outcomes of children with complicated pneumonia. Outcomes were similar in patients undergoing initial chest tube placement with or without fibrinolysis. Those undergoing VATS received fewer additional drainage procedures but had no differences in LOS compared with other strategies.


Subject(s)
Drainage/methods , Pleural Effusion/complications , Pleural Effusion/therapy , Pneumonia/complications , Pneumonia/therapy , Adolescent , Child , Child, Preschool , Cohort Studies , Female , Humans , Infant , Male , Pleural Effusion/physiopathology , Pneumonia/physiopathology , Retrospective Studies , Treatment Outcome
10.
Proteins ; 49(3): 398-402, 2002 Nov 15.
Article in English | MEDLINE | ID: mdl-12360529

ABSTRACT

Entropy-enthalpy (SH) compensation occurs when a small change in DeltaG is caused by large, and nearly compensatory, changes in DeltaH and DeltaS. It is considered a ubiquitous property of reactions in water. Because water is intimately involved in protein stability, SH compensation among protein variants, if it exists, could lead to important knowledge about protein-water interactions. In light of recent theoretical work on SH compensation, we gathered thermodynamic data for >200 protein variants to seek evidence for the simplest quantitative model of SH compensation (i.e., The van't Hoff denaturation enthalpy divided by the van't Hoff denaturation entropy is a constant). We conclude that either the data are insufficient to support the idea that quantitative SH compensation is a general feature of variant proteins or that such compensation does not exist. This study reinforces the idea that DeltaH-versus-DeltaS plots should not be used to provide evidence for SH compensation.


Subject(s)
Models, Theoretical , Proteins/chemistry , Cytochrome c Group/chemistry , Cytochrome c Group/genetics , Entropy , Humans , Micrococcal Nuclease/chemistry , Micrococcal Nuclease/genetics , Muramidase/chemistry , Muramidase/genetics , Mutation , Protein Denaturation , Ribonuclease T1/chemistry , Ribonuclease T1/genetics , Thermodynamics
SELECTION OF CITATIONS
SEARCH DETAIL
...